Peter Nash is Associate Professor in the Department of Medicine at the University of Queensland, and Director of the Rheumatology Research Unit on the Sunshine Coast. Dr Nash has Chaired the Professional Affairs Committee and the Therapeutics Committee , and serves on the Scientific Advisory Committee of the Australian Rheumatology Association. He is a former member of the Therapeutics Committee of the Australia and New Zealand Bone and Mineral Society. He remains on the International Steering Committee for GRAPPA.
Dr Nash and his group at the Rheumatology Research Unit have been involved with pivotal registration clinical trials for all modern targeted biologic therapies and osteoporosis therapies. He has published more than 100 peer-reviewed papers and 5 book chapters, and acts as reviewer for a number of journals and serves on the editorial board of Annals of the Rheumatic Diseases and RMD Open. His special interests include metabolic bone disease and novel therapeutics.